IMPEDX DIAGNOSTICS, INC.

Medtech · Private

Portable diagnostic system using magnetic nanoparticles and microfluidic electrical impedance spectroscopy to detect tuberculosis and perform drug susceptibility testing in sputum samples within 3 day

Claim this profile

Follows are private to you and power your alerts

Updated

Sector
Medtech
Total capital
$1.3M
Federal grants
$1.3M
4 awards · 2016–2019
Rank in peer group#77 of 542
Private capital raised
None on recordNo Form D filings on SEC EDGAR. Some raises are not filed.
Federal contracts
None on recordNo federal contract awards found.
Granted patents
1
1 pending · first 2022
Rank in peer group#106 of 542

Capital timeline

2016201720182019FEDERAL ↑EQUITY ↓Cumulative $1.3M$225K$290K$730K$100K
2016201720182019FEDERAL ↑EQUITY ↓Cumulative $1.3M$225K$290K$730K$100K

Latest events

  • Federal grantAgriculture · Electronic System For Detecting Low-levels Of Bacteria In Yeast Culture Inoculum$100K
  • Federal grantNSF · Phase II · SBIR Phase II: Universal electronic platform and system for rapid (direct from sample) phenotypic Antibiotic Susceptibility Testing (AST)$730K
  • Federal grantHealth and Human S · Phase I · Low-cost portable system for the rapid detection and drug resistance profiling of Tuberculosis in low resource environments.$290K
  • Federal grantNSF · Phase I · SBIR Phase I: Low cost portable system for the rapid detection and drug resistance profiling of Tuberculosis$225K

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 542 peers

Line = median

Medtech · Device

  • Federal grants#77 · top 14%
  • Granted patents#106 · top 20%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

Researcher links verified by same-company patents and grants
  • Stephen O'ConnorResearcherExecutive Officer, DirectorLinked by 1 patent · $515K in grants as PI
  • John HoweDirectorNamed in SEC Form D filings
  • Kimberly MislickDirectorNamed in SEC Form D filings
  • Shramik SenguptaDirectorNamed in SEC Form D filings

What it has protected

USPTO · 1 granted of 2

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .